Therapeutic experiences of alcohol-related Korsakoff's psychosis;Therapeutische erfahrungen beim alkoholbedingten Korsakow-syndrom

Nervenarzt

Volumn 70, Issue 9, 1999, Pages 790-794

  Mrazek, M ^a   Menges, C ^b   Steffes, J ^b   Thelen, B ^b   Erkwoh, R ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

Clonidine; Fluvoxamine; Korsakoff's psychosis; Therapy

Indexed keywords

CLOMETHIAZOLE; CLONIDINE; FLUVOXAMINE; HALOPERIDOL; THIAMINE;

ADULT; ALCOHOLISM; ARTICLE; CASE REPORT; HUMAN; KORSAKOFF PSYCHOSIS;

ADRENERGIC ALPHA-AGONISTS; ADULT; ALCOHOL WITHDRAWAL DELIRIUM; ALCOHOLISM; ANTI-ANXIETY AGENTS; BRAIN; CLONIDINE; DRUG THERAPY, COMBINATION; FLUVOXAMINE; HUMANS; KORSAKOFF SYNDROME; MALE; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0032868490     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050513     Document Type: Article

References (32)

1. Baker KG, Halliday GM, Kril JJ, Harper CG (1996) Chronic alcoholics without Wernicke-Korsakoff syndrome or cirrhosis do not lose serotonergic neurons in the dorsal raphe nucleus. Alcohol Clin Exp Res 20:61-66
2. Baker KG, Halliday GM, Kril JJ, Harper CG (1996) Chronic alcoholism in the absence of Wernicke-Korsakoff syndrome does not result in the loss of serotonergic neurons from the median raphe nucleus. Metab Brain Dis 11:217-226
3. Bowden S, Bardenhagen F, Ambrose M, Whelan G (1994) Alcohol, thiamin deficiency, and neuropsychological disorders. Alcohol Alcoholism [Suppl] 2: 267-272
4. 2-antagonist piperoxane. Brain Res 112:413-419
5. Clark CR, Geffen GM, Geffen LB (1986) Role of monoamine pathways in attention and effort: effects of clonidine and methylphenidate in normal adult humans. Psychopharmacology 90:35-39
6. Cook CC, Thomson AD (1997) B-complex vitamins in the prophylaxis and treatment of Wernicke-Korsakoff syndrome. Br J Hosp Med 57:461-465
7. Coull JT (1994) Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5:116-126
8. Frith CD, Dowdy J, Ferrier IN, Crow TJ (1985) Selective impairment of paired associate learning after administration of a centrally-acting adrenergic agonist (clonidine). Psychopharmacology 87:490-493
9. Frith CD, McGinty MA, Gergel I, Crow TJ (1989) The effects of scopolamine and clonidine upon the performance and learning of a motor skill. Psychopharmacology 98:120-125
10. Halliday G, Ellis J, Heard R, Caine D, Harper C (1993) Brainstem serotonergic neurons in chronic alcoholics with and without the memory impairment of Korsakoff's psychosis. J Neuropath Exper Neurol 52:567-579
11. Langlais PJ, Mair RG, Whalen PJ, McCourt W, McEntee WJ (1988) Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease. Psychopharmacology 95:250-25
12. Lishman WA (1987) Organic psychiatry. The psychological consequences of cerebral disorder, 2nd edn. Blackwell, Oxford
13. Mair RG, McEntee WJ (1986) Cognitive enhancement in Korsakoff's psychosis by clonidine: a comparison with L-Dopa and ephedrine. Psychopharmacology (Berlin) 88: 374-380
14. Martin PR, Mc Cool BA, Singleton CK (1995) Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakow syndrome. Metabol Brain Dis 10:45-55
15. Martin PR, Adinoff B, Eckardt MJ, Stapleton JM, Bone GA, Rubinow DR, Lane EA, Linnoila M (1990) Effective pharmacotherapy of alcoholic amnestic disorder with fluvoxamine. Preliminary findings. Arch Gen Psychiatry 46:617-621
16. Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingärtner H, Linnoila M, Eckardt MJ (1995) Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuropsychopharmacology 5:27-33
17. Matussek N, Ackenheil M, Herz A (1984) The dependence of the clonidine growth hormone test on alcohol drinking habits and the menstrual cycle. Psychoneuroendocrinology 9:173-177
18. McEntee WJ, Mair RG (1978) Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. Science 202:905-907
19. McEntee WJ, Mair RG (1980) Memory enhancement in Korsakoff's psychosis by clonidine: further evidence for a noradrenergic deficit. Ann Neurol 7:466-470
20. McEntee WJ, Mair RG (1990) The Korsakoff syndrome: a neurochemical perspective. Trends Neurosci 13:340-344
21. McEntee WJ, Mair RG, Langlais PJ (1981) Clonidin in Korsakoff disease: pathophysiologic and therapeutic implications. Progr Clin Biol Res 71:211-223
22. McEntee WJ, Mair RG, Langlais PJ (1984) Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders. Neurology 34:648-652
23. 99mTc-Exametazime in anterior cingulate cortex in Korsakoff's psychosis. Psychol Med 24:63-61
24. Nutt D (1987) Alpha-2-adrenoceptor function during ethanol withdrawal. Ann Int Med 107:880-883
25. O'Carroll RE, Moffoot AP, Ebmeier KP, Murray C, Goodwin GM (1993) Korsakoff's syndrome, cognition and clonidine. Psychol Med 23: 341-347
26. O'Carroll RE, Moffoot AR Ebmeier KP, Goodwin GM (1994) Effects of fluvoxamine treatment on cognitive functioning in the alcoholic Korsakoff syndrome. Psychopharmacology (Berlin) 116:85-88
27. Preuß UW, Soyka M (1997) Das Wernicke-Korsakow-Syndrom: Klinik, Pathophysiologie und therapeutische Ansätze. Fortschr Neurol Psychiatr 65:413-420
28. Rommelspacher H, Schmidt LG, Helmchen H (1991) Pathobiochemie und Pharmakotherapie des Alkoholentzugssyndroms. Nervenarzt 62:649-657
29. Schied H-W, Mann K (1989) Die Behandlung des Delirium tremens und des Alkoholentzugssyndroms. In: Schied H-W, Heimann &ding7A;, Mayer &ding7A; (Hrsg) Der chronische Alkoholismus. Fischer, Stuttgart New York, S 285-300
30. Soyka M (1995) Die Alkoholkrankheit - Diagnose und Therapie. Chapman & Hall, London Glasgow Weinheim
31. Stapelton JM, Eckardt MJ, Martin P, Adinoff B, Roehrich L, Bone G, Rubinow D, Linniola M (1988) Treatment of alcoholic organic brain syndrome with the serotonine reuptake inhibitor Fluvoxamine: a preliminary study. Adv Alcohol Subst Abuse 7:47-51
32. Zubarán C, Fernandes JG, Rodnight R (1997) Wernicke-Korsakoff syndrome. Postgrad Med J 73:27-31